AGRX
Agile Therapeutics
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
26 hedge funds and large institutions have $28M invested in Agile Therapeutics in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
4% more funds holding
Funds holding: 25 → 26 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
26
Holding in Top 10
1
Calls
$386K
Puts
$2K
Top Buyers
| 1 | +$12.7M | |
| 2 | +$293K | |
| 3 | +$195K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$157K |
| 5 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$151K |
Top Sellers
| 1 | -$82.6K | |
| 2 | -$27.1K | |
| 3 | -$9K | |
| 4 |
Morgan Stanley
New York
|
-$7K |
| 5 |
JGC
J. Goldman & Co
New York
|
-$6K |